Home - Products - GPCR/G Protein - Cannabinoid Receptor - CB 65

CB 65

CAS No. 913534-05-1

CB 65( —— )

Catalog No. M35264 CAS No. 913534-05-1

CB 65 is a high affinity and selective CB2 receptor agonist with Ki values of 3.3 and > 1000 nM for CB2 and CB1 receptors respectively.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	79	In Stock
10MG	119	In Stock
25MG	201	In Stock
50MG	293	In Stock
100MG	417	In Stock
200MG	589	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

CB 65
Note

Research use only, not for human use.
Brief Description

CB 65 is a high affinity and selective CB2 receptor agonist with Ki values of 3.3 and > 1000 nM for CB2 and CB1 receptors respectively.
Description

CB65 is a potent and high affinity CB2 selective agonist with a Ki value of 3.3 nM. CB65 exhibits a Ki of >1000 nM for CB1 receptor.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

GPCR/G Protein
Target

Cannabinoid Receptor
Recptor

Cannabinoid Receptor
Research Area

——
Indication

——

Chemical Information

CAS Number

913534-05-1
Formula Weight

417.93
Molecular Formula

C22H28ClN3O3
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 5 mg/mL (11.96 mM; Ultrasonic (<60°C)
SMILES

C(CN1CCOCC1)N2C=3C(C(=O)C(C(NC4CCCCC4)=O)=C2)=CC=C(Cl)C3
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. CB 65 is a high affinity and selective CB2 receptor agonist; Ki?values are 3.3 and > 1000 nM for CB2 and CB1 receptors respectively. ?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Cannabichromene

Cannabichromene is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyrin-1 (TRPA1).
COR659

COR659 is a 2-acylaminothiophene derivative able to suppress alcohol and chocolate self-administration in rats, likely via positive allosteric modulation of the GABAB receptor and antagonism/inverse agonism at the cannabinoid CB1 receptor.
Bronze Red

Bronze Red

Sign In Join Free